Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2100071	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2021-03-11	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2021-11-18	view
JYSB2100070	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2021-03-11	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2021-11-18	view
JYHZ2100008	卡铂注射液	carboplatin	Injection	Chemical Drugs	License Renew	2021-01-20	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Corden Pharma Latina SpA;Bristol-Myers Squibb SA	Certificate Issued	2021-07-20	view
JXSL2100005	Relatlimab/Nivolumab固定剂量复方注射液	nivolumab;relatlimab	Injection	Biological Products(1)	Import Drug Application	2021-01-09	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Company	In Review	2021-01-08	view
JXSS2000067	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2020-12-25	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2021-08-31	view
JXSS2000066	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2020-12-25	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2021-08-31	view
JXHB2000060	BMS-986165片	deucravacitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2020-12-25	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Piramal Healthcare Uk Ltd;Bristol-Myers Squibb Company	In Review	2020-12-23	view
JXHB2000061	BMS-986165片	deucravacitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2020-12-18	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Piramal Healthcare Uk Ltd;Bristol-Myers Squibb Company	In Review	2020-12-17	view
JXHB2000029	BMS-986165片	deucravacitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2020-09-23	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Piramal Healthcare Uk Ltd;Bristol-Myers Squibb Company	In Review	2020-09-22	view
JXHB2000030	BMS-986165片	deucravacitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2020-09-23	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Piramal Healthcare Uk Ltd;Bristol-Myers Squibb Company	In Review	2020-09-22	view
JXSL2000009	NKTR-214	bempegaldesleukin	Injection	Biological Products	Import Drug Application	2020-01-21	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Nektar Therapeutics	In Review	2020-01-20	view
JXSS1900071	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Import Drug Application	2019-12-26	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2021-07-05	view
JXSS1900070	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2019-12-26	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2021-07-05	view
JXSS1900069	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2019-12-26	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2021-07-05	view
JXSS1900072	伊匹木单抗注射液	ipilimumab	Injection	Biological Products	Import Drug Application	2019-12-26	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	Certificate Issued	2021-07-05	view
JYHB1901304	阿哌沙班片	apixaban	Tablet	Chemical Drugs	Supplementary Application	2019-11-09	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Manufacturing Company;Bristol-Myers Squibb / Pfizer Eeig	Certificate Issued	2020-01-06	view
JYHB1901305	阿哌沙班片	apixaban	Tablet	Chemical Drugs	Supplementary Application	2019-11-02	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Manufacturing Company;Bristol-Myers Squibb / Pfizer Eeig	Certificate Issued	2020-01-06	view
JXHL1900279	BMS-986165片	deucravacitinib	Tablet	Chemical Drugs(1)	Import Drug Application	2019-11-01	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Company	In Review	2019-10-31	view
JYHB1901182	BMS-986165	deucravacitinib	Active ingredient	Chemical Drugs	Supplementary Application	2019-10-15	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Company	In Review	2019-10-14	view
JYHB1900824	盐酸达拉他韦片	daclatasvir dihydrochloride	Tablet	Chemical Drugs	Supplementary Application	2019-07-03	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb (Singapore) Pte Ltd;Astrazeneca Pharmaceuticals Lp	Filed	2019-07-12	view